ViroPharma announces the first EU market to launch Plenadren for treatment of adrenal insufficiency (PR Newswire, 20 September 2012)

21 Sept 2012


ViroPharma has announced the launch of Plenadren (modified-release hydrocortisone), reported to be the first new treatment option for adrenal insufficiency in the EU in 50 years, in Denmark.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story